Material Transfer Agreement Template for New Zealand
Generate a bespoke document
What is a Material Transfer Agreement?
The Material Transfer Agreement (MTA) is a specialized legal instrument used when one organization (the Provider) transfers tangible research materials to another organization (the Recipient) for research purposes. This agreement type is essential in New Zealand's research and development landscape, particularly where valuable biological, chemical, or physical materials are shared between institutions. The document must comply with New Zealand's specific regulatory framework, including the Hazardous Substances and New Organisms Act 1996, Treaty of Waitangi obligations, and biosecurity requirements. MTAs are crucial for protecting intellectual property rights, ensuring appropriate use of materials, maintaining confidentiality, and establishing clear parameters for research activities. They are particularly important in collaborative research projects, academic-industry partnerships, and international research initiatives.
About the Material Transfer Agreement
A Material Transfer Agreement (MTA) is a crucial legal document that governs the transfer of tangible research materials between organizations in New Zealand. Whether you're sharing biological samples, chemical compounds, or specialized research tools, an MTA protects both parties by establishing clear terms for use, ownership, and responsibilities. These agreements are particularly important in New Zealand's collaborative research environment, where universities, Crown Research Institutes, and private companies frequently exchange materials to advance scientific knowledge.
When do you need this document?
You need an MTA whenever your organization is transferring or receiving research materials that have potential commercial, scientific, or strategic value. This includes situations where a university is sharing cell lines with a pharmaceutical company, when Crown Research Institutes provide genetic material to agricultural researchers, or when international collaborations involve the exchange of specialized compounds. MTAs are also essential when your research involves human biological samples, genetically modified organisms, or materials that could pose biosecurity risks. The agreement becomes particularly critical if the materials could lead to intellectual property development or commercial applications.
Key legal considerations
Your MTA must clearly define permitted and prohibited uses of the transferred materials, ensuring the recipient cannot use them for commercial purposes unless explicitly allowed. Intellectual property clauses are crucial, particularly regarding any derivatives or improvements made using the original materials. You should include comprehensive liability and indemnification provisions to protect against potential damages, especially when dealing with hazardous substances. Confidentiality obligations must be clearly established to protect proprietary information, while publication rights need careful consideration to balance scientific transparency with commercial interests. The agreement should also specify material return or destruction requirements upon project completion.
Legal requirements in New Zealand
Under New Zealand law, your MTA must comply with the Hazardous Substances and New Organisms Act 1996 if transferring biological materials or potentially hazardous substances. This requires appropriate classification, handling procedures, and safety protocols. The Biosecurity Act 1993 governs international material transfers, mandating proper import/export permits and quarantine procedures to protect New Zealand's unique ecosystem. If your materials involve human biological samples or associated data, the Privacy Act 2020 requires specific consent and data protection measures. The Patents Act 2013 implications must be considered for any materials that could lead to patentable discoveries. Additionally, if working with indigenous genetic resources or traditional knowledge, you must consider Treaty of Waitangi obligations and ensure appropriate consultation with relevant iwi or Māori organizations.
GOVERNING LAW
Applicable law
This Material Transfer Agreement is drafted to comply with New Zealand law. Key legislation includes:
Patents Act 2013: Governs intellectual property rights in New Zealand, relevant for protecting any patentable innovations or discoveries that might arise from the transferred materials.
Privacy Act 2020: Required consideration if the MTA involves human biological materials or associated personal data.
Biosecurity Act 1993: Crucial for international material transfers, governing the import and export of biological materials to prevent risks to New Zealand's biosecurity.
Contract and Commercial Law Act 2017: Provides the fundamental legal framework for contractual agreements in New Zealand, including aspects like formation, interpretation, and enforcement of contracts.
Treaty of Waitangi Act 1975: Consideration required if the materials involve indigenous biological resources or traditional knowledge, ensuring compliance with Treaty principles and consultation requirements.
Human Tissue Act 2008: Relevant if the MTA involves the transfer of human tissue or biological materials, governing collection, use, and transfer of human tissue.
Fair Trading Act 1986: Ensures fair trading practices and prohibits misleading conduct in trade, relevant for commercial aspects of material transfer.
Explore 208,390+ legal templates
Explore 208,390+ legal templates
Genie's Security Promise
Genie is the safest place to draft. Here's how we prioritise your privacy and security.
Your data is private:
We do not train on your data; Genie's AI improves independently
All data stored on Genie is private to your organisation
Your documents are protected:
Your documents are protected by ultra-secure 256-bit encryption
We are ISO27001 certified, so your data is secure
Organizational security:
You retain IP ownership of your documents and their information
You have full control over your data and who gets to see it